Locations
San Francisco, CA, USA
industry
Biotechnology · Consumer Products · DeepTech · Health
Size
1 - 10 employees
Stage
Pre Seed
founded in
2023
Taxa Technologies is focused on engineering the human microbiome through innovative solutions, particularly in the realm of designer probiotics for personal care. The company is backed by a $2.5M pre-seed funding round, indicating strong investor interest and potential for growth in a challenging market. Their unique approach to microbiome engineering sets them apart, as they invite scientists to collaborate on solving complex genetic recoding challenges. This positions Taxa Technologies as a pioneering player in the biotechnology sector, aiming to revolutionize personal care products with scientifically advanced probiotics.
Something looks off?